ArticleHuman vaccines & immunotherapeutics2026
Brief report: Effectiveness and safety of recombinant zoster vaccine in inflammatory bowel disease patients aged 18 years and older: A matched cohort and self-controlled case series study.
Maheen Humayun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.